Cargando…
免疫检查点抑制剂风湿性毒副反应诊治建议
Immune checkpoint inhibitors (ICIs) have made remarkable breakthroughs in cancer treatment. However, the widely use of ICIs is associated with a spectrum of immune-related adverse events (irAEs). These adverse events can affect any organ system. In this article, we have made a systemic review about...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817434/ https://www.ncbi.nlm.nih.gov/pubmed/31650952 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.12 |
| _version_ | 1783463418861191168 |
|---|---|
| collection | PubMed |
| description | Immune checkpoint inhibitors (ICIs) have made remarkable breakthroughs in cancer treatment. However, the widely use of ICIs is associated with a spectrum of immune-related adverse events (irAEs). These adverse events can affect any organ system. In this article, we have made a systemic review about the clinical characteristics of rheumatic irAEs, and also summarized irAEs in patients with pre-exsiting rheumatic disease. We also focus on the management of rheumatic irAEs. |
| format | Online Article Text |
| id | pubmed-6817434 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68174342019-11-12 免疫检查点抑制剂风湿性毒副反应诊治建议 Zhongguo Fei Ai Za Zhi 免疫检查点抑制剂专题 Immune checkpoint inhibitors (ICIs) have made remarkable breakthroughs in cancer treatment. However, the widely use of ICIs is associated with a spectrum of immune-related adverse events (irAEs). These adverse events can affect any organ system. In this article, we have made a systemic review about the clinical characteristics of rheumatic irAEs, and also summarized irAEs in patients with pre-exsiting rheumatic disease. We also focus on the management of rheumatic irAEs. 中国肺癌杂志编辑部 2019-10-20 /pmc/articles/PMC6817434/ /pubmed/31650952 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.12 Text en 版权所有©《中国肺癌杂志》编辑部2019 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
| spellingShingle | 免疫检查点抑制剂专题 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| title | 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| title_full | 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| title_fullStr | 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| title_full_unstemmed | 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| title_short | 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| title_sort | 免疫检查点抑制剂风湿性毒副反应诊治建议 |
| topic | 免疫检查点抑制剂专题 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817434/ https://www.ncbi.nlm.nih.gov/pubmed/31650952 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.12 |
| work_keys_str_mv | AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì AT miǎnyìjiǎnchádiǎnyìzhìjìfēngshīxìngdúfùfǎnyīngzhěnzhìjiànyì |